OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS

OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS

Bibliografski detalji
Glavni autori:	Sumner-Jones, S, McCormick, D, Coles, R, Pringle, I, McLachlan, G, Collie, D, Vrettou, C, Davies, J, Alton, E, Gill, DR, Hyde, S
Format:	Journal article
Izdano:	2009

Slični predmeti

3-STEP TAQMAN RT-PCR: ULTIMATE MESSENGER RNA DETECTION SENSITIVITY FOR CF GENE THERAPY CLINICAL TRIALS
od: McCormick, D, i dr.
Izdano: (2009)

Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes.
od: Davies, L, i dr.
Izdano: (2008)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
od: Davies, J, i dr.
Izdano: (2009)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
od: Alton, E, i dr.
Izdano: (2012)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
od: Alton, E, i dr.
Izdano: (2012)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''
od: Davies, J, i dr.
Izdano: (2009)

Towards gene therapy for cystic fibrosis: Biodistribution of GL67A/pGM169 DNA and mRNA following aerosol delivery to the mouse lung
od: Pringle, I, i dr.
Izdano: (2008)

The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes.
od: Davies, L, i dr.
Izdano: (2012)

Development of highly sensitive TaqMan RT-PCR assays for quantifying vector mRNA in human samples
od: Sumner-Jones, S, i dr.
Izdano: (2008)

Quantifying non-viral gene transfer by real-time PCR: a cautionary tale
od: Coles, R, i dr.
Izdano: (2009)

Topical delivery of NF-kb decoy related oligodeoxynucleotides reduces pro-inflammatory cytokine response associated with cationic lipid: pDNA vector delivery to murine lungs
od: Varathalingam, i dr.
Izdano: (2004)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
od: Griesenbach, U, i dr.
Izdano: (2011)

Secreted Gaussia luciferase as a sensitive reporter gene for in vivo and ex vivo studies of airway gene transfer.
od: Griesenbach, U, i dr.
Izdano: (2011)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
od: Hyde, S, i dr.
Izdano: (2015)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
od: Alton, E, i dr.
Izdano: (2013)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
od: Alton, E, i dr.
Izdano: (2013)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
od: Gill, DR, i dr.
Izdano: (2010)

Delivery of genes into the CF airway
od: Gill, D, i dr.
Izdano: (2014)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
od: Pringle, I, i dr.
Izdano: (2018)

Moving lentiviral-based gene therapy into a first-in-man CF trial
od: Griesenbach, D, i dr.
Izdano: (2015)

CF‐based optimisation for saliency detection
od: Yuzhen Niu, i dr.
Izdano: (2018-06-01)

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
od: Pringle, I, i dr.
Izdano: (2018)

Genetic medicines for CF: Hype versus reality
od: Alton, E, i dr.
Izdano: (2016)

Optimizing aerosol gene delivery and expression in the ovine lung.
od: McLachlan, G, i dr.
Izdano: (2007)

Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung.
od: Pringle, I, i dr.
Izdano: (2007)

BrdU Pulse Labelling In Vivo to Characterise Cell Proliferation during Regeneration and Repair following Injury to the Airway Wall in Sheep
od: Yahaya, B., i dr.
Izdano: (2013)

BrdU Pulse Labelling In Vivo to Characterise Cell Proliferation during Regeneration and Repair following Injury to the Airway Wall in Sheep
od: B. Yahaya, i dr.
Izdano: (2013-01-01)

Development of an immunocytochemical assay to detect human CFTR expression following gene therapy
od: Davidson, H, i dr.
Izdano: (2008)

Composition of Herpesvirus Ribonucleoprotein Complexes
od: Eric S. Pringle, i dr.
Izdano: (2020-07-01)

Characterization of transgene expression and pDNA distribution of the suctioned kidney in mice
od: Natsuko Oyama, i dr.
Izdano: (2017-01-01)

Towards a first-in-human trial with a pseudotyped lentivirus
od: Alton, EW, i dr.
Izdano: (2020)

EXERCISE CAPACITY AND PHYSICAL ACTIVITY IN PATIENTS WITH CF: DATA FROM THE UK CF GENE THERAPY CONSORTIUM (UKCFGTC) 'RUN-IN' STUDY
od: Saunders, C, i dr.
Izdano: (2010)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
od: Alton, E, i dr.
Izdano: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
od: Alton, E, i dr.
Izdano: (2014)

Gene therapy for respiratory diseases; progress and a changing context
od: Alton, EWFW, i dr.
Izdano: (2020)

Hybrid fibrous architectures-mediated gene transfer by pDNA nanoparticles into macrophages
od: Jana Ghitman, i dr.
Izdano: (2024-10-01)

Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice
od: Marie-Lynn Cuypers, i dr.
Izdano: (2023-04-01)

Development of pDNA and Recombinant VSV Vectored Vaccines for Immunization Against HIV
od: Udem Steve
Izdano: (2005-12-01)

Suitable Promoter for DNA Vaccination Using a pDNA Ternary Complex
od: Tomoaki Kurosaki, i dr.
Izdano: (2024-05-01)

gl $$ \mathfrak{gl} $$ N Higgsed networks
od: Yegor Zenkevich
Izdano: (2021-12-01)